Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three insulin-based strategies in poorly controlled type 2 diabetes mellitus
2004-002036-25Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin glargine, human insulin and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Sanofi. Primary endpoint: Glycated hemoglobin (HbA1c) at end of study. Started Feb 2005; status: completed.
02
Drugs
insulin glarginehuman insulinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002036-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002036-25.